Format

Send to

Choose Destination
J Orthop Surg Res. 2015 Feb 3;10:24. doi: 10.1186/s13018-014-0144-x.

Determining the clinical importance of treatment benefits for interventions for painful orthopedic conditions.

Author information

1
Analgesic Solutions, 232 Pond Street, Natick, MA, 01760, USA. nkatz@analgesicsolutions.com.
2
Tufts University School of Medicine, 274 Tremont Street, Boston, MA, 02111, USA. nkatz@analgesicsolutions.com.
3
Analgesic Solutions, 232 Pond Street, Natick, MA, 01760, USA. fpaillard@analgesicsolutions.com.
4
Tufts University School of Medicine, 274 Tremont Street, Boston, MA, 02111, USA. evanekman@earthlink.net.
5
Appalachian Regional Orthopaedic & Sports Medicine Center, Appalachian State University Department of Athletics, 870 State Farm Road, Suite 100, Boone, NC, 28607, USA. evanekman@earthlink.net.

Abstract

The overarching goals of treatments for orthopedic conditions are generally to improve or restore function and alleviate pain. Results of clinical trials are generally used to determine whether a treatment is efficacious; however, a statistically significant improvement may not actually be clinically important, i.e., meaningful to the patient. To determine whether an intervention has produced clinically important benefits requires a two-step process: first, determining the magnitude of change considered clinically important for a particular measure in the relevant population and, second, applying this yardstick to a patient's data to determine whether s/he has benefited from treatment. Several metrics have been devised to quantify clinically important differences, including the minimum clinically important difference (MCID) and clinically important difference (CID). Herein, we review the methods to generate the MCID and other metrics and their use and interpretation in clinical trials and practice. We particularly highlight the many pitfalls associated with the generation and utilization of these metrics that can impair their correct use. These pitfalls include the fact that different pain measures yield different MCIDs, that efficacy in clinical trials is impacted by various factors (population characteristics, trial design), that the MCID value is impacted by the method used to calculate it (anchor, distribution), by the type of anchor chosen and by the definition (threshold) of improvement. The MCID is also dependent on the population characteristics such as disease type and severity, sex, age, etc. For appropriate use, the MCID should be applied to changes in individual subjects, not to group changes. The MCID and CID are useful tools to define general guidelines to determine whether a treatment produces clinically meaningful effects. However, the many pitfalls associated with these metrics require a detailed understanding of the methods to calculate them and their context of use. Orthopedic surgeons that will use these metrics need to carefully understand them and be aware of their pitfalls.

PMID:
25645576
PMCID:
PMC4327973
DOI:
10.1186/s13018-014-0144-x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center